Sin embargo, el informe puede estar disponible en español por un costo adicional.
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Eye Health Supplements Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Ingredient Type
6.1 Lutein and Zeaxanthin
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Antioxidants
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Omega-3 Fatty Acids
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Coenzyme Q10
6.4.1 Market Trends
6.4.2 Market Forecast
6.5 Flavonoids
6.5.1 Market Trends
6.5.2 Market Forecast
6.6 Alpha-Lipoic Acid
6.6.1 Market Trends
6.6.2 Market Forecast
6.7 Others
6.7.1 Market Trends
6.7.2 Market Forecast
7 Market Breakup by Indication
7.1 Age-related Macular Degeneration (AMD)
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Cataract
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Dry Eye Syndrome
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Inflammation
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 Others
7.5.1 Market Trends
7.5.2 Market Forecast
8 Market Breakup by Formulation
8.1 Tablets
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Capsules
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Powder
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Others
8.4.1 Market Trends
8.4.2 Market Forecast
9 Market Breakup by Region
9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2 Asia-Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast
10 SWOT Analysis
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 Alliance Pharma PLC
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.1.3 Financials
14.3.1.4 SWOT Analysis
14.3.2 Amway International (Alticor)
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.3 Bausch & Lomb Incorporated
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.3.3 Financials
14.3.3.4 SWOT Analysis
14.3.4 Eyescience Labs
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.5 Kemin Industries Inc.
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.6 Novartis AG
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.6.3 Financials
14.3.6.4 SWOT Analysis
14.3.7 NutraChamps
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.8 Nutrivein
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
14.3.9 Pfizer Inc.
14.3.9.1 Company Overview
14.3.9.2 Product Portfolio
14.3.9.3 Financials
14.3.9.4 SWOT Analysis
14.3.10 The Nature's Bounty Co.
14.3.10.1 Company Overview
14.3.10.2 Product Portfolio
14.3.11 Vitabiotics Ltd.
14.3.11.1 Company Overview
14.3.11.2 Product Portfolio
14.3.12 ZeaVision LLC
14.3.12.1 Company Overview
14.3.12.2 Product Portfolio